Tag: Apomorphine

According to military sources, Blue Lotus is currently undetectable by routine drug screens despite its psychoactive properties. This has led to confusion and concerns for many individuals, prompting the question: can blue lotus show on a drug test?

Contrary to its name, the active compound apomorphine found in Blue Lotus (Nymphaea caerulea) does not contain morphine or bind to opioid receptors [1.3.2, 1.4.5]. The question, **does blue lotus have morphine?**, arises from a misunderstanding of its pharmacology, which is centered around different psychoactive alkaloids.

Depictions of the sacred Blue Lotus appear on the walls of ancient Egyptian tombs dating back to the 14th century B.C.. Often asked 'What is the blue flower drug?', the answer refers to *Nymphaea caerulea*, a water lily with psychoactive properties that has been used medicinally and recreationally for millennia.

Although historically derived from morphine, the medication known as apomorphine does not contain morphine or bind to opioid receptors. It is primarily recognized as a potent dopamine agonist used to manage "off" episodes in people with advanced Parkinson's disease by mimicking dopamine's effect in the brain.

In February 2025, the U.S. Food and Drug Administration (FDA) approved Onapgo, the first infusion-based apomorphine therapy for advanced Parkinson's disease in the United States. This innovative treatment delivers a continuous infusion of medication via a wearable pump during waking hours.